Conduit Pharmaceuticals I... (CDT)
NASDAQ: CDT
· Real-Time Price · USD
1.62
-0.05 (-2.99%)
At close: Aug 15, 2025, 3:59 PM
1.71
5.56%
After-hours: Aug 15, 2025, 07:24 PM EDT
Conduit Pharmaceuticals Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
Period Ending | Jun 29, 2025 | Mar 30, 2025 | Dec 31, 2024 | Sep 29, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 |
Net Income | 61.01M | 51.94M | -2.41M | -6.46M | -5.38M | -3.57M | 1.78M | 1.99M | -2.51M | -2.17M | -3.07M | 206.91K | -117.54K | -307K |
Depreciation & Amortization | 32.07M | 29.78M | 452K | n/a | 23.52M | 26.99M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Stock-Based Compensation | 6.83M | 7.78M | 362K | 356K | 483K | 431K | 189K | 10K | n/a | n/a | n/a | n/a | n/a | n/a |
Other Working Capital | n/a | -490K | -2M | 1.03M | -298K | -104K | -4.43M | 1.5M | 939K | 47K | 827K | 293.4K | 186.08K | -432.64K |
Other Non-Cash Items | -17.87M | -80.84M | 194K | 2.24M | 2.35M | 1.51M | -2.55M | -5.53M | 1.14M | 149K | 1.36M | -609.92K | -191.59K | 16K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | n/a | -1.21M | -2.42M | 1.86M | 610K | -201K | -4.22M | 1.76M | 939K | 47K | 827K | 293.4K | 182.21K | -497K |
Operating Cash Flow | 82.03M | 7.44M | -3.81M | -2M | -1.51M | -2.36M | -4.8M | -1.78M | -429K | -1.97M | -880K | -109.61K | -126.92K | -788K |
Capital Expenditures | -25.15M | -32.2M | n/a | -41K | -10K | -24.25M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | 7.92M | -296.45M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | 980K | -490K | -490K | n/a | n/a | 389.94K | -234.54K | -155.4K | n/a | n/a | n/a | -134.9M |
Sales Maturities Of Investments | n/a | n/a | 85K | -276K | 276K | n/a | n/a | -114.86M | 828.78K | 114.03M | n/a | n/a | n/a | n/a |
Other Investing Acitivies | 9K | 106K | 375.8M | 25.38M | -224K | 60K | 497K | 228K | -190.24K | -114.12M | -54K | n/a | n/a | n/a |
Investing Cash Flow | -25.14M | -24.18M | 85K | 96K | -224K | -24.19M | 497K | -114.24M | 404K | -243K | -54K | n/a | n/a | -134.9M |
Debt Repayment | n/a | -2.13M | 707K | 1.74M | n/a | n/a | -8.49M | 1.53M | 11K | 2.22M | 422K | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 114.07M | -114.07M | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | -2.01M | -2.02M | -6.12M | -2.04M | n/a | -2.08M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -17.42M | -100.69M | 6.12M | 2.04M | 113K | -65.79M | 8.07M | 8.64M | 114.27M | n/a | n/a | n/a | n/a | n/a |
Financial Cash Flow | -19.42M | -96.78M | 4.21M | 1.74M | 113K | -64.94M | -414K | 124.74M | 11K | 2.22M | 933K | n/a | n/a | 789K |
Net Cash Flow | 42.49M | -111.31M | 483K | -148K | -1.63M | -2.38M | -4.42M | 8.37M | 269.76K | -337.78K | -382.3K | -109.61K | -126.92K | -46.55K |
Free Cash Flow | 56.88M | -24.76M | -3.81M | -2.04M | -1.52M | -26.61M | -4.8M | -1.78M | -429K | -1.97M | -880K | -109.61K | -126.92K | -788K |